SCHEMBL22619232

SCHEMBL22619232

CSNc1cccc(C2CCN(Cc3c[nH]c4ccccc34)C2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.62
DRD4 P21917 6/20 0.62
DRD3 P35462 6/20 0.62
CYP2D6 P10635 2/20 0.51
BCHE P06276 1/20 0.51
HTR6 P50406 1/20 0.49
LMNA P02545 2/20 0.48
HTT P42858 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 1/20 0.48
JAK2 O60674 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.44
SOS1 Q07889 2/20 0.44
KRAS P01116 1/20 0.44
GLA P06280 1/20 0.43
PDE2A O00408 1/20 0.43
OPRM1 P35372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22619089 0.90 DRD2 (0.62) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22619109 0.89 DRD2 (0.66) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22619062 0.86 DRD2 (0.57) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22619078 0.86 DRD2 (0.57) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22608968 0.84 DRD2 (0.60) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22609031 0.84 DRD2 (0.60) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22609017 0.83 DRD2 (0.59) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22619026 0.81 DRD2 (0.87) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22619022 0.81 DRD2 (0.67) DRD2DRD4DRD3CYP2D6BCHE
SCHEMBL22619235 0.81 DRD2 (0.67) DRD2DRD4DRD3CYP2D6BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733670-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF Mediconns (Shanghai) Biopharmaceutical Co., Ltd (CN) 2020-11-04 EP disclosed